Tender detail
Open-house pharmaceutical discount agreements for melatonin, excluding 2 mg prolonged-release tablets (ATC N05CH01)
Summary
AOK Bayern intends to conclude non-exclusive discount agreements with interested pharmaceutical companies for medicinal products containing melatonin, excluding 2 mg prolonged-release tablets (ATC N05CH01). The contract period begins no earlier than 1 December 2026 and ends on 30 November 2028.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.